Drug facts

Molecule

Ibuprofen (Motrin IB)

Generics already compete: 32 makers on the market. 41 A-rated products from 13 makers substitute at the counter.

Motrin was first approved by the FDA before 1982 under NDA 017463; the application holder is Mcneil Consumer Healthcare Div Mcneil Ppc Inc. The Orange Book lists NDA 017463 as discontinued.

The latest NADAC for IBUPROFEN 600 MG TABLET is $0.05 per unit (as of 10/28/2026).

Holder Mcneil Consumer Healthcare Div Mcneil Ppc IncApplication NDA 017463Approved before 1982

01Patents and exclusivity

When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.

Latest patent
No Motrin patent listed in the Orange Book
Orange Book
Later patents, other products
Caldolor 03/16/2032
Orange Book

02Competition

Generics
32 generic makers
Orange Book
First generic approved
02/08/1985
Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Ibuprofen profile.See what is included

03Supply and price

FDA drug shortage
ClearNot on the current shortage list
FDA shortages
NADAC
$0.05 per unitIBUPROFEN 600 MG TABLET, mid-priced of 5 strengths, as of 10/28/2026
CMS NADAC
Latest recall
03/02/2026Class II, Ibuprofen, Strides Pharma Inc
FDA enforcement

04Product

Application holder
Mcneil Consumer Healthcare Div Mcneil Ppc Inc
Orange Book
Application
NDA 017463
Orange Book
First approved
before 1982
Orange Book
Dosage forms
capsule; solution; suspension; suspension/drops; tablet; tablet, chewable
Routes
intravenous, oral
Other brand names
AdvilAdvil Liqui-GelsAdvil Migraine Liqui-GelsCaldolorChildren's AdvilChildren's Advil-Flavored
Status
NDA 017463 discontinued
Orange Book

Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.